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Abstract 
 
Hepatocellular carcinoma (HCC) is a common malignancy with poor clinical outcome, whose 
histogenesis is the subject of intense debate. Specifically, expression of cytokeratins (CKs) 7 and  19, 
associated with aggressive biological behaviour, is proposed to reflect a possible progenitor-cell 
origin or tumour de-differentiation towards a primitive phenotype. This work addresses that  problem 
by studying CKs 7 and 19 expression in N-diethylnitrosamine (DEN)-induced mouse HCCs. ICR 
mice were divided into 6 DEN-exposed and 6 matched control groups. Samples were taken from each 
group at consecutive time points. Hyperplastic foci (13 lesions) occurred at 29 to 
40 weeks (groups 8, 10 and 12) with diffuse dysplastic areas (19 lesions) and with one hepatocellular 
adenoma (HCA) (at 29 weeks). HCCs (4 lesions) were observed 40 weeks after the first DEN 
administration (group 12). CKs 7 and 19 showed identical expression patterns and  located to large, 
mature hepatocytes, isolated or in small clusters. Hyperplastic foci and the single HCA were 
consistently negative for both markers while dysplastic areas and HCCs were positive. These results 
support the hypothesis that CKs 7 and 19 expression in hepatocellular malignancies result from a de-
differentiation process rather than from a possible progenitor cell origin. 
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Introduction 
 
Liver cancer is a major public health problem, with approximately 748 000 new cases diagnosed 
yearly (Ferlay et al. 2010). The majority of these cases are histologically classified as hepatocellular 
carcinomas (HCC) and occur mostly in older males in developing countries, due to the distribution 
of the risk factors (Motola-Kuba et al. 2006). HCCs are believed to emerge through a process of multi-
step carcinogenesis, but their histogenesis is still a matter of discussion. One long-established view is 
that normal mature hepatocytes undergo neoplastic transformation to originate pre- malignant lesions 
and that early-stage HCCs arise within such lesions, giving then place to high- grade carcinomas, 
originating a characteristic nodule-within-nodule structure (Sakamoto et al. 1991). However, it has 
also been hypothesized that a set of HCCs may originate from hepatic stem cells (Durnez et al. 2006; 
Lee et al. 2006). This hypothesis is supported by the expression patterns  of several hepatic 
differentiation markers. Cytokeratins (CKs) 8 and 18 are equally expressed by hepatocytes and bile 
duct cells, while cytokeratin (CK) 7 and CK19 are considered as markers of cholangiocytic 
differentiation (Strnad et al. 2008). Nevertheless, it has been observed that some HCCs express CKs 
7 and 19, as well as c-kit that is a hepatic stem cell marker (Kim et al. 2004), displaying an 
intermediate hepatocellular-cholangiocytic progenitor cell-like phenotype. Furthermore, expression 
of CK19 has been associated with poor prognosis (Uenishi et al. 2003; Ding et al. 2004; Durnez et al. 
2006). However, Shibuya and collaborators (Shibuya et al. 2011) have recently put forward another 
contribution to this debate by proposing that malignant hepatocytes may trans-differentiate (or de-
differentiate) into immature stem cell-like cells. An experimental carcinogenesis experiment may be 
useful to address this problem, by studying the expression of differentiation markers over time and 
thus determining whether tumours result from the clonal expansion of progenitor cells or de-
differentiate to acquire a progenitor cell-like phenotype. Over the years, several experimental rodent 
models have been used to study the pathogenesis of HCC, particularly mice and rats (Heindryckx 
et al. 2009). Chemically-induced 
4 
models using N-diethylnitrosamine (DEN) are long-established and among the most frequently used 
(Goldfarb et al. 1983). DEN belongs to the N-nitroso group and is widely known for its ability to 
induce tumours in a multiplicity of organs, including the liver, the stomach, the lung and the 
haematopoietic organs. DEN is a genotoxic, DNA-alkylating carcinogen that requires metabolic 
activation (Hecht et al. 1989). The first biotransformation step is hydroxylation to - 
hydroxylnitrosamine, mediated by cytochrome P450, which shows its highest activity in centrilobular 
hepatocytes (Kang et al. 2007). Upon cleavage of acetaldehyde an ethyldiazonium ion is formed, 
reacting with DNA and other nucleophiles, including DNA repair enzymes. DEN- induced mouse 
tumours often harbour H-ras activating mutations (Stahl et al. 2005). While activation of the Ras 
pathway is a common event in human hepatocarcinogenesis (Calvisi et al. 2006), mutations of the H-
ras proto-oncogene itself are less frequent and associated with a more aggressive biological behaviour 
(Wang et al. 2001). Accordingly, DEN-induced tumours are  thought to closely mimic the more 
aggressive human HCCs. 
The necessary development time after a single DEN administration for HCC depends on several 
factors, namely administered dose, administration route, age, sex and strain of the animals 
(Vesselinovitch & Mihailovich,1983; Vesselinovitch et al. 1984; Heindryckx et al. 2009). The present 
work employs a multiple dose DEN-induced mouse HCC model to study the expression of CKs 7 
and 19 in pre-neoplastic and neoplastic hepatic lesions. 
 
 
Materials and Methods 
 
 
Animals and experimental conditions 
 
One hundred and twenty male ICR mice with five weeks of age (Harlan, Barcelona) were housed at 
the bioterium of the University of Trás-os-Montes and Alto Douro, according to National (Portaria 
1005/92   dated   October  the   23
rd
)   and  European  (EU   Directive   2010/63/EU) legislation  and 
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submitted to one week of quarantine Mice were identified with ear cuts and kept in ventilated 
facilities, under controlled conditions of temperature (23±2ºC), light-dark cycle (12h light/12h dark) 
and relative humidity (50±10%), using hardwood bedding. Standard diet (Global Diet 2014, Harlan, 
Barcelona) and water were provided ad libitum. 
 
 
Experimental procedures 
 
At six weeks of age, all mice were randomly divided into twelve groups. Animals from groups 1, 3, 
5, 7, 9 and 11 (controls, CTL) were intraperitoneally injected with a saline solution weekly for eight 
consecutive weeks (administration route - i.p. once a week), whereas animals from groups 2, 4, 6, 8, 
10 and 12 (exposed groups) received DEN (Sigma-Aldrich) at a dose of 35mg per Kg of body weight 
(Heindryckx et al., 2012). Throughout the experimental protocol (Figure 1), animals were daily 
monitored for signs of distress. Food and water intake, as well as animal weights, were weekly 
recorded. Animals from groups 1 and 2, 3 and 4, 5 and 6, 7 and 8, 9 and 10 were euthanized at 8,  15, 
22, 29 and 36 weeks (W) after the first administration of DEN, respectively, by means of a  lethal 
dose of pentobarbital sodium, injected intraperitoneally. Euthanasia of animals from groups 
11 (40W CTL) and 12 (40W exposed) was performed at 40 weeks after the DEN first administration, 
because some mice of the DEN-exposed group exhibited external signs of distress. 
 
 
Sample collection and histological processing 
 
A complete necropsy was carried out in all animals in order to check for tumoral masses. The liver, 
brain, heart, lungs, spleen, stomach, intestine, pancreas, kidneys, adrenal glands, testes, 
gastrocnemius muscles and a dorsal skin sample were collected into 10% neutral buffered formalin 
and fixated for 48 hours. Posteriorly the samples were routinely processed and paraffin-embedded. 
 
 
Histological and immunohistochemical analysis 
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Histological sections (2µm-thick) were obtained and stained with haematoxylin and eosin (H&E)  for 
examination on light microscopy. The presence of haemorrhage and other vascular disorders, bile 
cysts, necrosis, apoptosis, nuclear and cytoplasmic changes/accumulations were noted. Proliferative 
hepatic lesions were classified as hyperplastic foci, hepatocellular adenoma (HCA) or HCC (Deschl 
et al. 2001). Furthermore, multifocal to regionally extensive, poorly-delimited dysplastic areas, 
showing loss or distortion of lobular architecture, irregular hepatocyte plates, moderate cell atypia 
and mitotic activity were classified as diffuse dysplasia. Immunohistochemical detection of CK7 and 
CK19 was performed on 2µm-thick sections using a standard peroxidase protocol. Heat-induced 
antigen retrieval was performed employing citrate buffer in a microwave for 15 minutes. Monoclonal 
anti-CK7 (RCK105) and anti-CK19 (A-3) were acquired from Santa Cruz Biotechnology, diluted in 
phosphate-buffered saline (1:500) and incubated with the tissue sections for one hour at room 
temperature. Immunoreactivity was detected using diaminobenzidine.  Negative controls were 
obtained by omitting the primary antibody. Bile duct epithelial cells were used as positive internal 
controls. 
 
 
Statistical analysis 
 
Data were expressed as mean±standard deviation (SD) and compared by one - way analysis of 
variance (ANOVA) followed by Tukey’s multiple comparison test at the 5% significant level 
(p<0.05). All tests were performed using the GraphPad Prism, version 5.01 (GraphPad Software, Inc., 
La Jolla, CA, USA). 
 
 
Results 
 
The mortality rate in the DEN group during the experimental protocol was 6.67% (4 out of 60 animals, 
one in group 2, another in group 10 and two in group 12). Despite the enrichment of cage 
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environment, male competitive behaviour was noticed, resulting in punctual injuries and focal loss of 
hair (barbering behavior). 
Regarding animal growth, the ponderal homogeneity index (iPH) and ponderal gain  (PG)  for control 
and DEN-exposed groups were calculated (Table 1). Drinking-water consumption was  lower in 
DEN-treated animals compared with control groups (not significant). Food intake was also lower in 
DEN-exposed groups. Statistically significant differences between groups were noticed during the 
assay at 29 and 36 weeks after the first DEN exposure, regarding final body weight (p<0.05). 
 
 
Control animals (Figure 3) did not show any changes to the normal hepatic architecture at any time 
point of the assay. Animals from group 2 (8W exposed) revealed acute toxic lesions, such as 
hepatocellular hydropic degeneration (Figure 4a) and necrosis. Animals from groups 4 and 6 (15W 
and 22W, exposed) revealed the same kind of lesions (Figures 4b and c, respectively). No  alterations 
to normal liver architecture were present. At the same time points, occasional cytoplasmic 
immunostaining for CKs 7 (Figure 5a, b and c, respectively) and 19 (Figure 6a, b and  c, respectively) 
was observed in the biliary epithelium and hepatocytes surrounding necrotic areas, in both exposed 
and control animals. 
Nodular hepatic lesions occurred from twenty-nine weeks after the first DEN administration and were 
often visible macroscopically (Figure 2). The first hyperplastic foci were observed in group 8 (29W 
exposed). Such foci were clearly delimited from the adjacent parenchyma, were composed of tight 
hepatocellular plates which compressed the hepatic sinusoids and showed distinct, basophilic or 
mixed type, cytoplasmic coloration (Figure 4d). Four out of 10 animals (40%) showed hepatic 
hyperplastic foci (six nodules, Table 2). One animal showing 2 hyperplastic foci also exhibited 
dysplastic changes in a distant and poorly-delimited area classified as diffuse dysplasia (10%) as well 
as a larger, well-defined nodule classified as a HCA (10). Dysplastic lesions (Figure 4e) were 
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composed of hepatocytes arranged in irregular and variably-oriented plates which disrupted normal 
liver architecture lacking the formation of distinguishable nodules. Hepatocytes were moderately 
pleomorphic showing significant variations in size and occasional cytoplasmic vacuoles. 
Pseudonucleoli and mitotic figures were present (1 per high-power field). The HCA was a large (1.0 
cm in diameter) nodule which compressed the adjacent parenchyma, composed of regularly- oriented 
hepatocellular trabeculae. Hepatocytes were smaller than adjacent cells, displaying basophilic 
cytoplasm and large, round nuclei with coarse chromatin and occasional mitotic figures (up to 1 
mitotic figure per high power field). Both dysplastic and adenomatous areas showed scattered 
immunopositive cells for CK7 and CK19, isolated or in groups of two to ten large mature hepatocytes 
(Figures 5e and 6e, respectively), while hyperplastic foci (Figures 5d and 6d) were consistently 
negative. Immunopositive cells in dysplastic areas were often located in the  subcapsular region or in 
centrilobular areas, around the central vein. Immunostaining was diffusely distributed in the 
cytoplasm and was moderate to strong. Antibodies against CK7 and CK19 consistently stained the 
same areas, with similar distribution and intensity. All animals from group 10 (36W exposed) showed 
extensive areas of diffuse hepatic dysplasia (10 out of 10 animals, 100%). Hyperplastic foci were 
recorded less frequently (2 out of 10 animals, 20%, a total of 3 nodules). As observed in group 8 (29W 
exposed), dysplastic areas showed scattered cells exhibiting moderate to strong immunostaining for 
CK7 and CK19, while hyperplastic foci remained consistently negative. Dysplastic areas also showed 
a sinusoidal accumulation of erythroblasts distributed in small foci of 2 to 20 cells. Occasionally, 
myeloid precursor cells were found in association with such foci. 
Four out of 8 (50%) animals from group 12 (40W exposed) exhibited large hepatic, soft, grey to light 
brown or occasionally haemorrhagic nodules, measuring up to 1.0 cm in diameter. Histologically, 
these nodules were classified as HCCs. These lesions arose within diffuse dysplastic areas and 
showed invasive growth and a multifocal distribution. HCCs (Figure 4f) were composed 
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of moderately to highly pleomorphic cells disposed in solid nests, trabeculae or, multifocally, pseudo-
acinar structures, supported by a loose fibrovascular stroma. Neoplastic cells showed moderate 
nuclear pleomorphism, a prominent nucleolus and up to four mitotic figures per high power field. 
Cells varied in size, were often vacuolated and frequently assumed a signet-ring morphology. 
Multifocally, variably sized intracytoplasmic hyaline bodies were present. Scattered cells or cell 
groups exhibiting moderate to strong cytoplasmic immunostaining for CK7 and CK19 were present 
(Figures 5f and 6f). Immunopositive hepatocytes were mostly large, little- or non- vacuolated cells, 
with vacuolated cells showing a fainter immunostaining. Immunostaining for both CKs was 
consistently present in the same areas. Groups of erythroblasts were present in all HCCs and were 
larger than those observed in dysplastic areas. In one instance, fully-differentiated bone marrow 
developed inside a carcinomatous nodule, with myeloid, erythroid, lymphoid and platelet precursors 
distributed between bone lamellae and adipocytes (Figure 3f). All animals from group 12 (40W 
exposed) showed diffuse dysplastic areas (8 out of 8 animals, 100%) and 3 out 8 (37.5%) showed 
hyperplastic foci (4 lesions in total). The immunostaining patterns observed in these lesions were 
identical to those observed in previous groups. 
 
 
Discussion 
 
The histogenesis of HCC is the subject of an intense debate. In fact, since some tumour subtypes show 
different biological behaviour, refining their histopathological classification has important 
consequences for patient treatment and prognosis (Ding et al. 2004; Durnez et al. 2006). HCCs with 
a progenitor cell-like phenotype express certain characteristic markers of cholangiocytes (Ding et  al. 
2004; Durnez et al. 2006). While CKs 8 and 18 are expressed by both hepatocytes and epithelial bile 
duct cells, CK7 and CK19 are used as markers of cholangiocytic differentiation (Strnad et al. 2008). 
In the present work, the expression of CKs 7 and 19 was studied in a murine model of chemical    
hepatocarcinogenesis,    in    non-neoplastic,    pre-neoplastic    and    neoplastic  tissues. 
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Immunopositive cells were not observed in control tissues in the early exposed groups, apart from 
bile duct epithelial cells and hepatocytes bordering necrotic foci. These were not small, scattered cells 
resembling hepatic progenitor cells but a continuous lining of large, mature hepatocytes. It seems 
likely that these hepatocytes are responding to liver damage and have suffered corresponding 
cytoskeletal rearrangements involving CKs 7 and 19 expression - a similar phenomenon was 
previously described in alcoholic steatohepatitis and cholestatic liver diseases (Vaneyken et al. 1989; 
Zatloukal et al. 2004). Activation of hepatic progenitor cells in the early stages following DEN 
exposure was not detected immunohistochemically. Hyperplastic foci are considered early pre-
neoplastic changes in the process of multi-step hepatocarcinogenesis. Overexpression of CKs 8 and 
18 has been described in hyperplastic foci in DEN-exposed RasH2, B6C3F1 and C57BL/6 mice 
(Kakehashi et al. 2010; Kawai et al. 2010; Kushida et al. 2011). These authors agree that CKs 8 and 
18-positive foci seem to be reliable markers for pre-malignant lesions in those mouse strains. 
Expression of CK19 has also been recently described in DEN-induced hyperplastic foci (especially 
in eosinophilic foci) and HCAs in C57BL/6 mice (Kushida et al. 2011). Andersen et al. (Anderson et 
al. 2010) also associated CK19 expression with malignancy and with malignant progression of pre-
neoplastic liver lesions in a rat model. 
In the present study, immunopostivity for CKs 7 and 19 was always coincident and distributed in 
small cell clusters or isolated cells, in a pattern resembling that described by Shibuya et al. (Shibuya 
et al. 2011) and not forming nodules as described by Kushida et al. (Kushida et al. 2011). However, 
in contrast with these last author’s findings, hyperplastic nodules were consistently negative  for both 
CK7 and CK 19. This discrepancy must be regarded with caution due to the low number of 
hyperplastic foci detected in the present study and the fact that these were basophilic or mixed instead 
of eosinophilic. On the other hand, immunopositive hepatocytes were found outside hyperplastic foci, 
scattered through diffuse dysplastic areas, and especially in subcapsular and centrilobular  areas  
(where  DEN  metabolic  activation  occurs  most  intensely).   Immunopositive 
11 
hepatocytes did not resemble hepatic progenitor cells, but were large, mature hepatocytes with 
abundant cytoplasm, a coarse nuclear chromatin pattern and, frequently, a prominent nucleolus, in 
agreement with the results of Shibuya et al. (Shibuya et al. 2011). A similar pattern was observed in 
all HCCs (although there were only four of these). The only diagnosed HCA showed an identical 
CK7/CK19 expression pattern as well. These results support the association of CK7 and CK19 
expression with hepatocellular malignancy in the mouse DEN-induced hepatocarcinogenesis model. 
Interestingly, immunopositivity for CKs 7 and 19 coincides with the presence of extramedullary 
haematopoiesis, consisting first of scattered groups of erythroblasts in dysplastic areas and then, of 
bone marrow foci in HCCs. Considering that the immature mouse liver is, physiologically, a 
haematopoietic organ, this finding provides yet another indication of the primitive or immature 
phenotype of these malignancies. Furthermore, bearing in mind that: a) all observed hyperplastic foci 
were CK7/CK19-negative, b) positive cells occurred isolated or in small clusters, rather than in 
nodules and c) positive cells showed hepatocellular rather than progenitor cell morphology, the 
present results give additional support to the hypothesis that CKs 7 and 19 expression in HCCs may 
result from de-differentiation of mature hepatocytes This is in line with the findings of Shibuya et al. 
(2011), but contrasts with results presented by other autors. In fact, Libbrecht et al. (2000) presented 
results suggesting that hepatic progenitor cells give rise to HCCs via small-cell dysplastic foci. Using 
an experimental appraoch, Dumble et al. (2002) showed that p53-null hepatic progenitor cells 
implanted in nude mice did give rise to tumors resembling HCCs. The discrepancy between these 
findings and our present results appears to lie in the different models used by each research group. 
Most human HCCs arise from a background of chronic liver disease, with hepatic progenitor cell 
activation. In our model, DEN preferentially targets centrilobular hepatocytes (not progenitor cells) 
over a 8-weeks period, with no evidence of early-stage progenitor cell activation. These results thus 
provide new perspectives on the mechanisms of hepatocarcinogenesis, especially on the contribution 
of the stem-cell phenotype in the context of DEN-induced carcinogenesis. 
12 
 
Acknowledgements 
 
The authors express their deepest appreciation to J.H. Teixeira and Lígia Lourenço for technical 
support in preparing some histological and immunohistochemical slides. The Authors gratefully 
acknowledge the financial support provided to N. Paula-Santos (BD/60280/2009)  by  the Foundation 
for Science and Technology (FCT) and Research Unit in Vila Real (POCTI-SFA-3- 616). 
 
 
 
References 
 
 
Anderson J, Loi R., Perra A., Factor V., Ledda-Columbano G., Columbano A. & Thorgeirsson S. 
(2010) Progenitor-derived hepatocelular carcinoma model in the rat. Hepatology 511401-1409. 
 
Calvisi D F, Ladu S., Gorden A., Farina M., Conner E. A., Lee J. S., Factor V. M. & Thorgeirsson 
 
S. S. (2006) Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 
130(4), 1117-1128. 
 
Deschl U., Cattley R., Harada T., Küttler K., Hailey J., Hartig F., Leblanc B., Marsman D. & Shirai 
 
T. International Classification of Rodent Tumors: The Mouse, In: International Classification of 
Rodent Tumors: The mouse. Mohr, U, Eds., Springer-Verlag, Heidelberg. 2001. 
 
Ding S J, Li Y., Tan Y. X., Jiang M. R., Tian B., Liu Y. K., Shao X. X., Ye S.  L., Wu J. R., Zeng  R., 
Wang H. Y., Tang Z. Y. & Xia Q. C. (2004) From proteomic analysis to clinical significance - 
Overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Molecular & 
Cellular Proteomics  3(1), 73-81. 
13 
Dumble M. L., Croager E. J., Yeoh G. C. T., Quail E. A. (2002) Generation and characterization of 
p53 null transformed hepatic progenitor cells: oval cells give rise to hepaticellular carcinoma. 
Carcinogenesis 23, 435-445. 
 
Durnez A, Verslype C., Nevens F., Fevery J., Aerts R., Pirenne J., Lesaffre E., Libbrecht L.,  Desmet 
V. & Roskams T. (2006) The clinicopathological and prognostic relevance of cytokeratin 7 and 19 
expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 49(2), 138-
151. 
 
Ferlay J, Shin H. R., Bray F., Forman D., Mathers C. & Parkin D. M. (2010) Estimates  of worldwide 
burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127(12), 2893-2917. 
 
Goldfarb S, Pugh T. D., Koen H. & He Y. Z. (1983) Preneoplastic and Neoplastic Progression During 
Hepatocarcinogenesis in Mice Injected with Diethylnitrosamine in Infancy. Environmental Health 
Perspectives  50(APR), 149-161. 
 
Hecht S S, Mirvish S. S., Gold B., Nagel D. & Magee P. N. (1989) Conference on Advances in the 
Biology and Chemistry of N-Nitroso and Related-Compounds. Cancer Research  49(5), 1327-1329. 
 
Heindryckx F, Colle I. & Van Vlierberghe H. (2009) Experimental mouse models for hepatocellular 
carcinoma research. International Journal of Experimental Pathology  90(4), 367-386. 
 
Heindryckx F, Kuchnio A, Casteleyn C, Coulon S, Olievier K, Colle I, Geerts A, Libbrecht L, 
Carmeliet P, Van Vlierberghe H (2012) Effect of prolyl hydroxylase domain-2 haplodeficiency on 
the hepatocarcinogenesis in mice. Journal of Hepatology 57, 61-68. 
14 
Kakehashi A, Kato A., Inoue M., Ishii N., Okazaki E., Wei M., Tachibana T. & Wanibuchi H. (2010) 
Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions. Toxicology and Applied 
Pharmacology  242(1), 47-55. 
 
Kang J S, Wanibuchi H., Morimura K., Gonzalez F. J. & Fukushima S. (2007) Role of CYP2E1 in 
diethyinitrosamine-induced hepatocarcinogenesis in vivo. Cancer Research  67(23), 11141-11146. 
 
Kawai M, Saegusa Y., Kemmochi S., Harada T., Shimamoto K., Shibutani M. & Mitsumori K. (2010) 
Cytokeratin 8/18 is a Useful Immunohistochemical Marker for Hepatocellular Proliferative Lesions 
in Mice. Journal of Veterinary Medical Science  72(3), 263-269. 
 
Kim H, Park C., Han K. H., Choi J. S., Kim Y. B., Kim J. K. & Park Y. N. (2004) Primary liver 
carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. Journal of Hepatology 40(2), 298-
304. 
 
Kushida M, Kamendulis L. M., Peat T. J. & Klaunig J. E. (2011)  Dose-Related Induction of  Hepatic 
Preneoplastic Lesions by Diethylnitrosamine in C57BL/6 Mice. Toxicologic Pathology 39(5), 776-
786. 
 
Lee J S, Heo J., Libbrecht L., Chu I. S., Kaposi-Novak P., Calvisi D. F., Mikaelyan A., Roberts L. R., 
Demetris A. J., Sun Z. T., Nevens F., Roskams T. & Thorgeirsson S. S. (2006) A novel prognostic 
subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nature Medicine  
12(4), 410-416. 
 
Libbrecht L., Desmet V., Van Damme B.,  Roskams T. (2000) The imunohistochemical phenotype 
of dysplastic foci in human liver: correlation with putative progenitor cells. Journal of Hepatology 
33, 76-84. 
15 
Motola-Kuba D, Zamora-Valdés D., Uribe M. & Méndez-Sánchez N. (2006) Hepatocellular 
carcinoma. An overview. Annals of Hepatology  5(1), 16-24. 
 
Sakamoto M, Hirohashi S. & Shimosato Y. (1991) Early Stages of  Multistep Hepatocarcinogenesis 
 
- Adenomatous Hyperplasia and Early Hepatocellular-Carcinoma. Human Pathology 22(2), 172- 178. 
 
Shibuya M, Kondo F., Sano K., Takada T. & Asano T. (2011) Immunohistochemical study of 
hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma. Journal of Hepato- 
Biliary-Pancreatic Sciences  18(4), 537-543. 
 
Stahl S, Ittrich C., Marx-Stoelting P., Kohle C., Altug-Teber O., Riess O., Bonin M., Jobst J.,  Kaiser 
S., Buchmann A. & Schwarz M. (2005) Genotype-phenotype relationships in hepatocellular tumors 
from mice and man. Hepatology  42(2), 353-361. 
 
Strnad P, Stumptner C., Zatloukal K. & Denk H. (2008) Intermediate filament cytoskeleton of the 
liver in health and disease. Histochemistry and Cell Biology  129(6), 735-749. 
 
Uenishi T, Kubo S., Yamamoto T., Shuto T., Ogawa M., Tanaka H., Tanaka S., Kaneda K. & 
Hirohashi K. (2003) Cytokeratin 19 expression in hepatocellular carcinoma predicts early 
postoperative recurrence. Cancer Science  94(10), 851-857. 
 
Vaneyken P, Sciot R. & Desmet V. J. (1989) A Cytokeratin Immunohistochemical Study of 
Cholestatic Liver-Disease - Evidence That Hepatocytes Can Express Bile Duct-Type Cytokeratins. 
Histopathology  15(2), 125-135. 
 
Vesselinovitch S D, Koka M., Mihailovich N. & Rao K. V. N. (1984) Carcinogenicity of 
Diethylnitrosamine in Newborn, Infant, and Adult Mice. Journal of Cancer Research and Clinical 
Oncology  108(1), 60-65. 
16 
Vesselinovitch S D & Mihailovich N. (1983) Kinetics of Diethylnitrosamine Hepatocarcinogenesis 
in the Infant Mouse. Cancer Research  43(9), 4253-4259. 
 
Wang Q, Lin Z. Y. & Feng X. L. (2001) Alterations in metastatic properties of hepatocellular 
carcinoma cell following H-ras oncogene transfection. World Journal of Gastroenterology 7(3), 335-
339. 
 
Zatloukal K, Stumptner C., Fuchsbichler A., Fickert P., Lackner C., Trauner M. & Denk H. (2004) 
The keratin cytoskeleton in liver diseases. Journal of Pathology  204(4), 367-376. 
 
 
 
 
 
 
17 
 
 
 
 
 
 
Figure 3 N-diethylnitrosamine-exposed mouse liver. H&E, 100x, bars = 100 lm. Inserts 400x, bars = 20 lm. (a) 
8W animal. Hepatocellular hydropic degeneration. Note intense cytoplasmic vacuolization. (b) 15W animal. Note 
coagulative necrosis focus. (c) 22W animal. Note nuclear changes with condensed, fuzzy chromatin. (d) 29W 
animal. Note small, mixed type hyperplastic nodule.(e) 36W animal. Note pleomorphic nuclei with 
pseudonucleoli over a dysplastic area. (f) 40W animal. Note a pseudo-acinar structure amidst a hepatocellular 
carcinoma. 
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Figure 4 N-diethylnitrosamine-exposed mouse liver. Immunostaining for CK7-Mayer’s haematoxylin, 100x, bars 
= 100 m. Inserts 400x, bars = 20 m. (a) 8W animal. (b) 15W animal. Note mitotic figure. (c) 22W animal. (d) 
29W animal. Note hyperplastic nodule on the upper half of the picture. (e) 36W animal. Note scattered, large, 
mature, immunopositive hepatocytes over a dysplastic area. (f) 40W animal. Note variably stained, mature, 
immunopositive hepatocytes scattered amidst a hepatocellular carcinoma. 
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Figure 5 N-diethylnitrosamine-exposed mouse liver. Immunostaining for CK19-Mayer’s haematoxylin, 100x, 
bars = 100 m. Inserts 400x,bars = 20 m. (a) 8W animal. (b) 15W animal. Note immunopositive biliary 
epithelium. (c) 22W animal. (d) 29W animal. Note hyperplastic nodule on the lower half of the picture. (e) 36W 
animal. Note scattered, large, mature, immunopositive hepatocytes over a dysplastic area. (f) 40W animal. Note 
variably stained, mature, immunopositive hepatocytes scattered amidst a hepatocellular carcinoma. 
 
 
 
Figure 6 Macroscopic features of livers from control and N-diethylnitrosamine-exposed ICR mice. (a) 40W 
control animal. (b) 36W exposed animal. Note hepatomegally with grey discoloration and irregular hepatic 
surface. (c) 40W exposed animal. Note distortion of hepatic lobes, haemorrhagic foci and multiple, grey nodular 
lesions.
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Table 1 - Animals body weights (g) (mean ± SD), ponderal homogeneity index (i PH) and ponderal gain 
(PG). 
 
 
8 
1-Control 
 
2-DEN 
31.16±2.60 
 
31.16±1.57 
39.86±3.35 
 
39.64±2.17 
2×27.06/(27.06+35.50) = 0.865 
 
2×28.90/(28.90+33.06) = 0.932 
(39.86-31.16/39.86)×100 = 21.82 
 
(39.64-31.16/39.64)×100 = 21.39 
 
 
15 
 
3-Control 
 
30.55±1.77 
 
45.40±4.40 
 
2×28.04/(28.04+33.66) = 0.909 
 
(45.40-30.55/45.40)×100 = 32.70 
 4-DEN 29.74±1.49 41.88±2.83
a
 2×27.70/(27.70+32.84) = 0.915 (41.88-29.74/41.88)×100 = 28.98 
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5-Control 
 
30.41±2.49 
 
44.39±4.24 
 
2×27.58/(27.58+35.40) = 0.875 
 
(44.39-30.41/44.39)×100 = 31.49 
 6-DEN 30.55±2.32 48.18±5.98 2×27.16/(27.16+34.00) = 0.888 (48.18-30.55/48.18)×100 = 36.59 
 
 
29 
 
7-Control 
 
29.63±1.62 
 
46.01±3.55 
 
2×27.20/(27.20+31.94) = 0.919 
 
(46.01-29.63/46.01)×100 = 35.60 
 8-DEN 29.84±2.48 44.32±5.81 2×25.62/(25.62+33.86) = 0.861 (44.32-29.84/44.32)×100 = 32.67 
 
 
36 
 
9-Control 
 
30.70±2.28 
 
51.13±6.19 
 
2×27.84/(27.84+34.80) = 0.888 
 
(51.13-30.70/51.13)×100 = 39.95 
 10-DEN 29.22±2.33 42.59±7.02
b
 2×26.04/(26.04+34.02) = 0.867 (42.59-29.22/42.59)×100 = 31.39 
 
 
40 
 
11-Control 
 
31.47±2.30 
 
50.07±2.41 
 
2×29.84/(29.84+33.10) = 0.948 
 
(50.07-31.47/50.07)×100 = 37.14 
 12-DEN 30.30±1.78 48.93±7.11 2×28.02/(28.02+33.76) = 0.907 (48.93-30.30/48.93)×100 = 38.07 
 
DEN: 
a
p=0.048, 
b
p=0.016 Statistically different from that of the control group (p<0.05). 
Weeks Group 
Initial body 
weight (g) 
Final body 
weight (g) 
i PH PG 
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Table 2 - Histological incidence of hyperplastic foci, dysplastic lesions, hepatocellular adenomas and carcinomas, 
and CK7/CK9 immunoexpression among DEN-exposed and control ICR mice. 
 
 
8 
weeks 
Control 
Group 1 
(n=10) 
Exposed 
Group 2 
(n=9) 
0 0 0 0 0 0 0 0 
 
0 0 0 0 0 0 0 0 
 
 
 
 
22 
weeks 
Control 
Group 5 
(n=10) 
Exposed 
Group 6 
(n=10) 
0 0 0 0 0 0 0 0 
 
0 0 0 0 0 0 0 0 
 
 
 
 
36 
weeks 
Control 
Group 9 
(n=10) 
Exposed 
0 0 0 0 0 0 0 0 
Group 10 
(n=9) 
20% 
(3 lesions) 
0 100% 
(10 lesions) 
100% 
(10 lesions) 
0 0 0 0 
 
 
HCA- hepatocellular adenoma, HCC- hepatocellular carcinoma 
Hyperplastic 
foci 
CK7
+
/19
+
 
hyperplastic foci 
Diffuse 
dysplasia 
CK7
+
/19
+
 
diffuse dysplasia 
HCA 
CK7
+
/19
+
 
HCA 
HCC 
CK7
+
/19
+
 
HCC 
Sacrifi 
ce 
Time 
points 
Animal 
groups 
% of animals with lesions 
(No. lesions per group) 
Control 
Group 3 
(n=10) 
Exposed 
Group 4 
(n=10) 
0 0 0 0 0 0 0 0 
15 
weeks 0 0 0 0 
0 0 0 0 
29 
weeks 
Control 
Group 7 
(n=10) 
Exposed 
Group 8 
(n=10) 
0 
0 
0 
0 
0 
0 
0 
0 
40% 
(6 lesions) 0 
10% 
(1 lesion) 
10% 
(1 lesion) 
10% 
(1 lesion) 
10% 
(1 lesion) 
0 0 
Control 
Group 11 
(n=10) 
Exposed 
Group 12 
(n=8) 
0 0 0 0 0 0 0 0 
40 
weeks 
37.5% 
(4 lesions) 0 
100% 
(8 lesions) 
100% 
(8 lesions) 
0 0 
50% 
(4 lesions) 
50% 
(4 lesions) 
